跳至主要内容
临床试验/NCT04278573
NCT04278573已完成2 期

Efficacy of Intralesional Vitamin D Injection for Treatment of Common Warts: A Randomized Controlled Trial

Stephen P. Merry1 个研究点 分布在 1 个国家目标入组 77 人开始时间: 2020年10月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
77
试验地点
1
主要终点
Complete Regression of Wart

研究概览

简要总结

Researchers are trying to find out if injecting Vitamin D into a wart is an effective treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients seen at the Mayo Clinic Rochester practices
  • Patients suffering from one or more cutaneous warts as diagnosed by the examining physician at baseline visit on typical diagnostic characteristics
  • Able to provide consent
  • Both recalcitrant and non-recalcitrant warts will be included

排除标准

  • Patients with prior use of home or office-based destructive treatments for this wart(s) in the last 1 month with salicylic acid (SA) or cryotherapy
  • Immunoadjuvant therapy for warts in the last 4 months (e.g Candida)
  • History of vitamin D injection of warts ever
  • High-dose vitamin D supplementation (>4,000 IU daily or equivalent) in the preceding 3 months
  • Pregnancy or lactation
  • Facial or genital warts
  • Lesions not felt by the examining clinician to be a wart (e.g., corns or calluses)
  • Immunosuppression (to include immunosuppressive medications or conditions as judged by the physician evaluating the patient at the baseline visit).
  • Allergy to sesame oil

研究组 & 干预措施

Vitamin D3 Treatment Group

Experimental

Subjects will receive a Vitamin D3 injection into their wart

干预措施: Vitamin D3 (Drug)

Placebo Group

Placebo Comparator

Subjects will receive a placebo injection into their wart

干预措施: Placebo (Drug)

结局指标

主要结局

Complete Regression of Wart

时间窗: 24 weeks

Number of subjects to have a complete resolution of cutaneous wart

次要结局

  • Regression of Wart at 4 Weeks(4 weeks)
  • Regression of Wart at 8 Weeks(8 weeks)
  • Regression of Wart at 12 Weeks(12 weeks)

研究者

发起方
Stephen P. Merry
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Stephen P. Merry

Principal Investigator

Mayo Clinic

研究点 (1)

Loading locations...

相似试验

Intralesional Vitamin D Injection for Treatment of... | 临床试验